No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Buy Rating for Lifestance Health Group Amid Potential Revenue Boost From Physician Fee Adjustments
Lifestance Health Group Secures New Credit Agreement
Express News | Lifestance Health Group Inc - Unit Enters Into Credit Agreement
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Goldman Sachs Upgrades LifeStance Health(LFST.US) to Buy Rating, Announces Target Price $10
Strong Growth Potential and Strategic Advancements Position Lifestance Health Group for Future Success